Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hallberg

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 4, 2015
N-Substituted pyrazole-3-carboxamides as inhibitors of human 15-lipoxygenaseBenjamin Pelcman, Andrei Sanin, Peter Nilsson, et al.
Bioorganic & Medicinal Chemistry|May 25, 2010
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibitionA K Mahalingam, Yiqian Wan, A M S Murugaiah, et al.
Bioorganic & Medicinal Chemistry|November 26, 2005
Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IVKarolina Ersmark, Martin Nervall, Hugo Gutiérrez-de-Terán, et al.
Eclinicalmedicine|November 1, 2021
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trialGöran Tornling, Rohit Batta, Joanna C Porter, et al.
Journal of Medicinal Chemistry|March 5, 2004
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivoYiqian Wan, Charlotta Wallinder, Berndt Johansson, et al.
RSC Medicinal Chemistry|January 22, 2021
Macrocyclic peptidomimetics as inhibitors of insulin-regulated aminopeptidase (IRAP)Nicholas Barlow, Sudarsana Reddy Vanga, Jonas Sävmarker, et al.
Journal of Medicinal Chemistry|December 13, 2006
Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studiesChristian Sköld, Susanne Winiwarter, Johan Wernevik, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 15, 2012
Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in ratsMichaël Shum, Sandra Pinard, Marie-Odile Guimond, et al.
Neurobiology of Disease|November 24, 2012
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expressionPawel Namsolleck, Francesco Boato, Katja Schwengel, et al.
Journal of Medicinal Chemistry|January 18, 2012
From the first selective non-peptide AT(2) receptor agonist to structurally related antagonistsA M S Murugaiah, Xiongyu Wu, Charlotta Wallinder, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|June 4, 2015
N-Substituted pyrazole-3-carboxamides as inhibitors of human 15-lipoxygenaseBenjamin Pelcman, Andrei Sanin, Peter Nilsson, et al.
Bioorganic & Medicinal Chemistry|May 25, 2010
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibitionA K Mahalingam, Yiqian Wan, A M S Murugaiah, et al.
Bioorganic & Medicinal Chemistry|November 26, 2005
Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IVKarolina Ersmark, Martin Nervall, Hugo Gutiérrez-de-Terán, et al.
Eclinicalmedicine|November 1, 2021
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trialGöran Tornling, Rohit Batta, Joanna C Porter, et al.
Journal of Medicinal Chemistry|March 5, 2004
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivoYiqian Wan, Charlotta Wallinder, Berndt Johansson, et al.
RSC Medicinal Chemistry|January 22, 2021
Macrocyclic peptidomimetics as inhibitors of insulin-regulated aminopeptidase (IRAP)Nicholas Barlow, Sudarsana Reddy Vanga, Jonas Sävmarker, et al.
Journal of Medicinal Chemistry|December 13, 2006
Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studiesChristian Sköld, Susanne Winiwarter, Johan Wernevik, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 15, 2012
Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in ratsMichaël Shum, Sandra Pinard, Marie-Odile Guimond, et al.
Neurobiology of Disease|November 24, 2012
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expressionPawel Namsolleck, Francesco Boato, Katja Schwengel, et al.
Journal of Medicinal Chemistry|January 18, 2012
From the first selective non-peptide AT(2) receptor agonist to structurally related antagonistsA M S Murugaiah, Xiongyu Wu, Charlotta Wallinder, et al.
Pageof 11